<?xml version="1.0" encoding="UTF-8"?>
<p>There was a study in Finland [
 <xref rid="B106-ijerph-17-01686" ref-type="bibr">106</xref>], in which the children who received a mumps vaccine at 14â€“20 months of age. This study found the seroconversion rate after vaccination with a Urabe strain vaccine was 95%, compared with seroconversion rate of 97% among children vaccinated with the Jeryl Lynn strain [
 <xref rid="B106-ijerph-17-01686" ref-type="bibr">106</xref>]. According to the information obtaining from an outbreak investigation of mumps in an Asian population in Singapore [
 <xref rid="B107-ijerph-17-01686" ref-type="bibr">107</xref>], the vaccine efficacies of the Jeryl Lynn strain, Urabe strain and Rubini strain mumps vaccines were 81%, 54%, and 55%, respectively.
</p>
